Lan N C, Gee K W, Bolger M B, Chen J S
Department of Molecular Pharmacology, School of Pharmacy, University of Southern California, Los Angeles 90033.
J Neurochem. 1991 Nov;57(5):1818-21. doi: 10.1111/j.1471-4159.1991.tb06388.x.
Neuroactive steroids, in particular 3 alpha-hydroxypregnanes, are allosteric modulators of the gamma-aminobutyric acidA (GABAA) receptor. Regionally selective expression of receptor subunit subtypes may account for differential responsiveness of tissues to GABAergic inhibition and neurosteroid modulatory effects. The effect of 5 alpha-pregnan-3 alpha-ol-20-one (epiallopregnanolone) on heterotropic cooperativity on the GABAA receptor complex has been studied in three subtypes of expressed recombinant human receptors and in rat brain and spinal cord. Steroid potentiation of [3H]flunitrazepam binding was greatest for the alpha 3 beta 1 gamma 2 receptor complex, whereas alpha 1 beta 1 gamma 2 and alpha 2 beta 1 gamma 2 complexes showed less than 100% enhancement in binding. Previous studies suggest that the spinal cord is devoid of alpha 1, whereas cerebellum is rich in alpha 1 subunits. Correspondingly, a differential enhancement of [3H]flunitrazepam binding in spinal cord (51%) versus cerebellum (28%) was also observed. The structure of neuroactive steroids is important in determinikng the extent of neuromodulatory activity. The 5 beta-pregnanes,5 beta-pregnan-3 alpha-ol-20-one (epipregnanolone) and 5 beta-pregnan-3 alpha,21-diol-20-one (5 beta-tetrahydrodeoxycorticosterone), were both less potent than their corresponding 5 alpha derivatives. A 3 alpha hydroxyl group is essential for neuromodulatory activity in the expressed receptors, as demonstrated by the observation that 5 alpha-pregnan-3 beta-ol-20-one (allopregnanolone) and 4-pregnen-3, 20-dione (progesterone) were both inactive.(ABSTRACT TRUNCATED AT 250 WORDS)
神经活性甾体,尤其是3α-羟基孕烷类,是γ-氨基丁酸A(GABAA)受体的变构调节剂。受体亚基亚型的区域选择性表达可能解释了组织对GABA能抑制和神经甾体调节作用的不同反应性。已在三种表达的重组人受体亚型以及大鼠脑和脊髓中研究了5α-孕烷-3α-醇-20-酮(表异孕烷醇酮)对GABAA受体复合物异向协同作用的影响。[3H]氟硝西泮结合的甾体增强作用在α3β1γ2受体复合物中最大,而α1β1γ2和α2β1γ2复合物的结合增强不到100%。先前的研究表明脊髓缺乏α1亚基,而小脑富含α1亚基。相应地,在脊髓(51%)和小脑(28%)中也观察到[3H]氟硝西泮结合的差异增强。神经活性甾体的结构对于确定神经调节活性的程度很重要。5β-孕烷类,5β-孕烷-3α-醇-20-酮(表孕烷醇酮)和5β-孕烷-3α,21-二醇-20-酮(5β-四氢脱氧皮质酮),两者的效力均低于其相应的5α衍生物。如观察到5α-孕烷-3β-醇-20-酮(别孕烷醇酮)和4-孕烯-3,20-二酮(孕酮)均无活性所表明的,3α羟基对于所表达受体中的神经调节活性至关重要。(摘要截短于250词)